Clinical Study Evaluating the Effect of Losartan

The pancreas is two organs packaged into one. The islets of Langerhans serve critical endocrine functions, and the exocrine portion is a major source of enzymes that are essential for digestion. Pancreatic cancer (PC) is more commonly referred to as pancreatic infiltrating ductal adenocarcinoma in addition to being the second leading cause of cancer death in the United States, after lung cancer in 2020. Whereas pancreatic cancer is the seventh cause of death from cancer in Asia in 2020. Although it is substantially less common than the other malignancies, pancreatic carcinoma is near the top

Trial Details

NCT ID
NCT06539806
Phase
NA
Sponsor
Tanta University
Status
RECRUITING
Cancer Type
Pancreatic Ductal Adenocarcinoma Pancreatic Cancer
Interventions
  • Losartan 50mg Tab
Locations (sample)
  • Tanta, Egypt|30.78847,31.00192

Key Eligibility Criteria

  • Male and female pancreatic cancer patients aged ≥ 50 years old.
  • Hypertensive patient with BP ≥ 140/90 mm Hg.
  • Histologically confirmed metastatic pancreatic adenocarcinoma; or locally advanced pancreatic cancer patients.
  • All included patients must sign an informed consent

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Ductal Adenocarcinoma Pancreatic Cancer Trials on Trialify →